Congrats & Farewell All, page-21

I should rephrase my previous post: "hot stocks that I intend to invest in at this point with my profits from VLA."

Don't get me wrong. I think IMU has potential but is associated with a high amount of risk (especially inherent in Australian biotech). We are still waiting on efficacy results in human studies. As far as I know, the only results published were for metastatic breast cancer to determine toxicity and safety. They're now undertaking Phase 1b/2 studies on gastric cancer in Asia and we're yet to hear about the results for that clinical trial.

The point is that it's too soon for me to form a more firm opinion about whether IMU will "shake the cancer immunology world". Hence, the reason why I've got a tiny holding in it. I hope you're right though especially given the mysterious trading halt announcement today.

Counter bid for VLA. Not sure. Would like to hear from others.